Full View

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development

SA Cohen, C Kellogg, O Equils - Human vaccines & …, 2021 - Taylor & Francis
The novel coronavirus SARS-CoV-2 emerged in China in 2019 and quickly spread globally,
causing a pandemic. There is an urgent need to develop vaccines against the virus, and …
被引用次数：28 相关文章
[PDF] scienceopen.com

[PDF][PDF] Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development

SA Cohen, C Kellogg, O Equils - HUMAN VACCINES & …, 2021 - scienceopen.com
The novel coronavirus SARS-CoV-2 emerged in China in 2019 and quickly spread globally,
causing a pandemic. There is an urgent need to develop vaccines against the virus, and …

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development

SA Cohen, C Kellogg, O Equils - Human vaccines & …, 2021 - pubmed.ncbi.nlm.nih.gov
The novel coronavirus SARS-CoV-2 emerged in China in 2019 and quickly spread globally,
causing a pandemic. There is an urgent need to develop vaccines against the virus, and …

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.

SA Cohen, C Kellogg, O Equils - Human Vaccines & …, 2020 - europepmc.org
The novel coronavirus SARS-CoV-2 emerged in China in 2019 and quickly spread globally,
causing a pandemic. There is an urgent need to develop vaccines against the virus, and …
[HTML] nih.gov

[HTML][HTML] Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development

SA Cohen, C Kellogg, O Equils - Human Vaccines & …, 2021 - ncbi.nlm.nih.gov
The novel coronavirus SARS-CoV-2 emerged in China in 2019 and quickly spread globally,
causing a pandemic. There is an urgent need to develop vaccines against the virus, and …